Kura Oncology (KURA) Shares Issued (2015 - 2025)
Kura Oncology (KURA) posted quarterly Shares Issued of $9.5 million for Q4 2025, down 26.12% year-over-year from $12.9 million in Q4 2024, and down 26.12% quarter-over-quarter from $12.9 million in Q4 2024.
Kura Oncology (KURA) Shares Issued (2015 - 2025) Analysis & Trends
Kura Oncology (KURA) has reported Shares Issued for 11 consecutive years, with $9.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Issued fell 26.12% year-over-year to $9.5 million; the TTM figure through Dec 2025 stood at $9.5 million (down 26.12% YoY), while the FY2025 annual figure was $9.5 million, down 26.12% from the prior year.
- Shares Issued declined to $9.5 million in Q4 2025 per KURA's latest filing, from $12.9 million in the prior quarter.
- Across five years, Shares Issued topped out at $12.9 million in Q4 2024 and bottomed at $7.0 million in Q4 2021.
- Historically, Shares Issued has averaged $9.6 million across 5 years, with a median of $9.5 million in 2025.
- Annual changes were most pronounced in 2021 — Shares Issued soared 38.44% — and 2025, when it dropped 26.12%.
- Kura Oncology's Shares Issued stood at $7.0 million in 2021, then gained by 21.21% to $8.4 million in 2022, then increased by 22.22% to $10.3 million in 2023, then rose by 25.31% to $12.9 million in 2024, then retreated by 26.12% to $9.5 million in 2025.
- Business Quant data shows KURA's Shares Issued at $9.5 million in Q4 2025, $12.9 million in Q4 2024, and $10.3 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Kura Oncology | 966.11 Mn | 966.11 Mn | 20.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.53 Mn |
| Dec 31, 2025 | 9.53 Mn |
| Dec 31, 2024 | 12.90 Mn |
| Dec 31, 2024 | 12.90 Mn |
| Dec 31, 2023 | 10.30 Mn |
| Dec 31, 2023 | 10.30 Mn |
| Dec 31, 2022 | 8.43 Mn |
| Dec 31, 2022 | 8.43 Mn |
| Dec 31, 2021 | 6.95 Mn |
| Dec 31, 2021 | 6.95 Mn |
| Dec 31, 2020 | 5.02 Mn |
| Dec 31, 2020 | 5.02 Mn |
| Dec 31, 2019 | 4.08 Mn |
| Dec 31, 2019 | 4.08 Mn |
| Dec 31, 2018 | 3.19 Mn |
| Dec 31, 2018 | 3.19 Mn |
| Dec 31, 2017 | 2.23 Mn |
| Dec 31, 2017 | 2.23 Mn |
| Dec 31, 2016 | 331,000.00 |
| Dec 31, 2016 | 331,000.00 |